Literature DB >> 26915

Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine.

M Field, L H Graf, W J Laird, P L Smith.   

Abstract

A partially purified preparation of the heat-stable enterotoxin of Escherichia coli caused a rapid and persistent increase in electric potential difference and short-circuit current when added in vitro to the luminal surface of isolated rabbit ileal mucosa. As little as 1 ng/ml produced an easily detectable response. Under short-circuit condition, the enterotoxin abolished net Cl- absorption; this change was half that produced by theophylline, which stimulated net secretion. The enterotoxin did not change cyclic AMP concentration but caused large and persistent increases in cyclic GMP concentration. The electrical and nucleotide responses exhibited similar and unusually broad concentration-dependences and maximal effects could not be demonstrated. Theophylline elevated cyclic GMP concentration 3-fold both in the presence and absense of the enterotoxin, suggesting no effect of the toxin on cyclic GMP phosphodiesterase. Guanylate cyclase [GTP pyrophosphatelyase(cyclizing); EC 4.6.1.2] activity in a crude membrane fraction from intestinal epithelial cells was stimulated 7-fold by the enterotoxin. These results suggest that guanylate cyclase stimulation is the basis for the toxin's diarrheagenic effect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 26915      PMCID: PMC392652          DOI: 10.1073/pnas.75.6.2800

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Ca ionophore-stimulated ion secretion in rabbit ileal mucosa: relation to actions of cyclic 3',5'-AMP and carbamylcholine.

Authors:  J E Bolton; M Field
Journal:  J Membr Biol       Date:  1977-06-30       Impact factor: 1.843

2.  Adenylate and guanylate cyclase activities and cellular differentiation in rat small intestine.

Authors:  H Quill; M M Weiser
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

3.  The localization of guanylate cyclase in rat small intestinal epithelium.

Authors:  H R De Jonge
Journal:  FEBS Lett       Date:  1975-05-01       Impact factor: 4.124

4.  Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.

Authors:  J M Hughes; F Murad; B Chang; R L Guerrant
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

5.  Stimulation of guanylate cyclase of fibroblasts by free fatty acids.

Authors:  D Wallach; I Pastan
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

6.  Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli.

Authors:  J F Alderete; D C Robertson
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Effects of some hormonal and other factors on the excretion of guanosine 3',5'-monophosphate and adenosine 3',5'-monophosphate in rat urine.

Authors:  J G Hardman; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

8.  Relationships among heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  C L Gyles
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

9.  Catecholamine effects on cyclic AMP levels and ion secretion in rabbit ileal mucosa.

Authors:  M Field; H E Sheerin; A Henderson; P L Smith
Journal:  Am J Physiol       Date:  1975-07

10.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975
View more
  201 in total

Review 1.  Intestinal ion transport and the pathophysiology of diarrhea.

Authors:  Michael Field
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors.

Authors:  Qais Al-Awqati
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

Review 4.  E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.

Authors:  Ralph A Giannella; Elizabeth A Mann
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

5.  Nucleotide regulation of heat-stable enterotoxin receptor binding and of guanylate cyclase activation.

Authors:  L C Katwa; C D Parker; J K Dybing; A A White
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

6.  [The heart as an endocrine organ: the discovery of a new hormone].

Authors:  R Gerzer
Journal:  Klin Wochenschr       Date:  1985-06-18

7.  Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents.

Authors:  M M ElDeib; C R Dove; C D Parker; T L Veum; G M Zinn; A A White
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Effect of alterations of basic amino acid residues of Escherichia coli heat-stable enterotoxin II on enterotoxicity.

Authors:  Y Fujii; Y Okamuro; S Hitotsubashi; A Saito; N Akashi; K Okamoto
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.

Authors:  F H Mourad; L J O'Donnell; J A Dias; E Ogutu; E A Andre; J L Turvill; M J Farthing
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

10.  Contribution of individual disulfide bonds to biological action of Escherichia coli heat-stable enterotoxin B.

Authors:  Y L Arriaga; B A Harville; L A Dreyfus
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.